Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014:2014:821381.
doi: 10.1155/2014/821381. Epub 2014 Mar 20.

A Preliminary Study on the Relationship between Platelet Serotonin Transporter Functionality, Depression, and Fatigue in Patients with Untreated Chronic Hepatitis C

Affiliations

A Preliminary Study on the Relationship between Platelet Serotonin Transporter Functionality, Depression, and Fatigue in Patients with Untreated Chronic Hepatitis C

Leonora Franke et al. Depress Res Treat. 2014.

Abstract

Objective and Methods. Although the interaction between fatigue and depression in patients with chronic hepatitis C infection (HCV) has been recognized, the biological correlates of this observation have yet to be reported. We addressed this issue by examining serotonin transporter- (SERT-) driven [(14)C]-serotonin uptake rate (SUR) and serotonin content in platelets of 65 untreated HCV patients and 65 healthy control subjects (HCS). All patients completed report questionnaires for fatigue, depression, and general psychopathology. Structured interviews were conducted by a board-certified psychiatrist. Results. Whereas 36 of the patients experienced fatigue of moderate-to-severe intensity, only 16 reported symptoms of depression (BDI score > 10). Mean SUR in patients with depressive symptoms was significantly higher relative to the HCS, corresponding to a large Cohen's effect size of d = 1.45 (95% CI = 0.66-1.83). Patients who rated their fatigue to have a marked impact on mood and activity displayed a moderate relationship between the BDI score and SUR (n = 18, r = 0.563, P = 0.015), which becomes stronger after controlling for age, gender, and thrombocytopenia (r part = 0.710, P = 0.003). In the univariate analysis, high fatigue interference score, thrombocytopenia, and high SUR were all significant predictors of depression. Conclusions. High SERT activity could be implicated in the expression of depressive symptoms especially in a subgroup of HCV patients who are feeling fatigue as markedly distressing.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Interference of fatigue with mood and activity in patients categorized in mild, moderate, and severe fatigue intensity groups. Note: mean fatigue interference score = arithmetic mean of BFI items 4–9; the dotted line indicates the cutoff for moderate-to-severe interference score.
Figure 2
Figure 2
Relationship between BDI and BFI intensity scale (a) or BFI interference scale (b) in patients with chronic hepatitis C. Note. BDI: Beck Depression Inventory; BFI: Brief Fatigue Inventory; BFI intensity score = mean of three items (fatigue at present, at its usual level, and at its worst); ● previous IFN-α treatment; ○ treatment-naïve.
Figure 3
Figure 3
Relationship between blood platelet count and 5HT uptake rate in platelets of male and female patients with chronic hepatitis C. Note: 5HT uptake rate is expressed in pMol/109 plts.×5 min and platelet count in ×109 plts./L blood.
Figure 4
Figure 4
Relationship between the BDI total score and platelet 5HT uptake rate in patients with differed degrees of fatigue interference with mood and activity. Note: the dotted line indicates the cutoff for classification of BDI scores into depressed and nondepressed.

Similar articles

Cited by

References

    1. Johnson ME, Fisher DG, Fenaughty A, Theno SA. Hepatitis C virus and depression in drug users. American Journal of Gastroenterology. 1998;93(5):785–789. - PubMed
    1. Dantzer R, O’Connor JC, Freund GG, Johnson RW, Kelley KW. From inflammation to sickness and depression: when the immune system subjugates the brain. Nature Reviews Neuroscience. 2008;9(1):46–56. - PMC - PubMed
    1. Leutscher PDC, Lagging M, Buhl MR, et al. Evaluation of depression as a risk factor for treatment failure in chronic hepatitis C. Hepatology. 2010;52(2):430–435. - PubMed
    1. Dwight MM, Kowdley KV, Russo JE, Ciechanowski PS, Larson AM, Katon WJ. Depression, fatigue, and functional disability in patients with chronic hepatitis C. Journal of Psychosomatic Research. 2000;49(5):311–317. - PubMed
    1. Kraus MR, Schafer A, Csef H, Scheurlen M, Faller H. Emotional state, coping styles, and somatic variables in patients with chronic hepatitis C. Psychosomatics. 2000;41(5):377–384. - PubMed

LinkOut - more resources